doi: 10.1016/0014-2964(77)90197-9.
Effect of BCG treatment on the evolution of cell-mediated immunity in mice bearing transplantable syngeneic tumors
- PMID: 852489
- DOI: 10.1016/0014-2964(77)90197-9
Item in Clipboard
Effect of BCG treatment on the evolution of cell-mediated immunity in mice bearing transplantable syngeneic tumors
Eur J Cancer (1965).
1977 Feb.
No abstract available
Similar articles
-
BCG as an adjunct to radiotherapy: a mouse model.Int J Radiat Oncol Biol Phys. 1977 Jul-Aug;2(7-8):685-91. doi: 10.1016/0360-3016(77)90048-7. Int J Radiat Oncol Biol Phys. 1977. PMID: 893172 No abstract available.
-
Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.Cancer Res. 1978 Aug;38(8):2492-500. Cancer Res. 1978. PMID: 667845 No abstract available.
-
Inhibition or enhancement of rat mammary tumors dependent on dose BCG.J Natl Cancer Inst. 1977 Jul;59(1):207-11. doi: 10.1093/jnci/59.1.207. J Natl Cancer Inst. 1977. PMID: 875054
-
Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitro.Int J Cancer. 1974 Jul 15;14(1):137-43. doi: 10.1002/ijc.2910140117. Int J Cancer. 1974. PMID: 4617706 Review. No abstract available.
-
Immunological intervention in neoplasia.Johns Hopkins Med J Suppl. 1974;3:131-56. Johns Hopkins Med J Suppl. 1974. PMID: 4371312 Review. No abstract available.
Cited by
-
Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancer.Urol Res. 1979 Jun 22;7(2):71-8. doi: 10.1007/BF00254684. Urol Res. 1979. PMID: 473445